CRO News
Reverb Therapeutics and Royalmount Join Forces for Lead Drug Development
Reverb Therapeutics has announced a collaboration with Montreal-based Royalmount Laboratories to support pre-IND enabling work on Reverb’s lead drug candidate, which is currently moving towards lead selection. The partnership will focus on critical bioanalytical and development tasks to prepare for
14 November 2024